Since higher ARHGEF15 expression levels were associated with a worse prognosis, we attempted to investigate the biological effects of overexpression or knockdown of ARHGEF15 on the cellular phenotype using pancreatic cancer cell lines. This evidence concerns the gene ARHGEF15 and familial pancreatic carcinoma.